Achieving Optimal Value from Medicines

Promising New Medicines in Development for Heart Disease & Stroke

06.24.13 | By

In a previous post, I shared my personal experience with stroke and encouraged readers to know the warning signs and symptoms of stroke.  A new report by PhRMA on Medicines in Development for Heart Disease and Stroke provides cause for optimism.

Week in Review

06.21.13 | By

As our President and CEO John Castellani emphasized, “Healthy debate is the foundation of progress and advancement.” This is something we feel very strongly about, and the initiatives announced this week show our commitment to being part of the ongoing dialogue around health care.

Hope for Kids with Amniotic Bands Syndrome

06.21.13 | By

Dean Kamen, a great scientist and inventor, said that “we now live in a world where technology, in many ways, has triumphed over death.”  As we look at the bigger picture around the value of innovation, particularly in a cost-containment environment, we must always keep this triumph in the back of our minds. 
 

PhRMA in POLITICO

06.20.13 | By

Last week, POLITICO sat down with President and CEO John Castellani to discuss how he is working to elevate the biopharmaceutical industry’s role as a thought leader within the health care ecosystem, as well as a key player in policy discussions within Washington and beyond.

PhRMA Statement on New Strategic Plan from the IP Enforcement Coordinator

WASHINGTON, D.C. (June 19, 2013) – Pharmaceutical Research and Manufacturers of America International Senior Vice President Rod Hunter issued the following statement today on the release of the second Joint Strategic Plan from the Intellectual Property Enforcement Coordinator (IPEC) Victoria Espinel:

New Coalition Seeks to Level the Playing Field for U.S. Businesses Competing in India

06.18.13 | By

A new alliance was launched today to begin educating the public and policymakers about the growing imbalance with the United States’ trading relationship with India and the potential consequences for American job losses if these concerns are not addressed.

Conversations

06.18.13 | By

Inventor Thomas Edison once said, “If we did all the things we are capable of, we would literally astound ourselves.”

PhRMA Joins with National Minority Quality Forum and Microsoft to Address Diversity in Clinical Trials

WASHINGTON, D.C. (June 18, 2013) – The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that it is partnering with the National Minority Quality Forum (NMQF) and Microsoft to help increase diversity in clinical trials.

PhRMA Statement on Supreme Court Ruling in Patent Settlement Case

WASHINGTON, D.C. (June 17, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President and General Counsel Mit Spears issued the following statement on the decision issued today by the U.S. Supreme Court in the case of Federal Trade Commission v. Actavis, Inc.:

Pages

Subscribe to RSS - Opinion